- Category
- Micro (2021-22)
- Udyam number
- UDYAM-GJ-01-0145898

Greatlee Pharmaceuticals Private Limited
About Greatlee Pharmaceuticals Private Limited
Data last updated:
Greatlee Pharmaceuticals Private Limited is a private limited company based in Sanand, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 February 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24299GJ2022PTC129545. Its GSTIN is 24AAJCG5969Q1ZO (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Riteshkumar Dineshkumar Thakkar and Krunal Dineshbhai Thakkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sanand, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.24 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹1.32 Lakh (net margin -1.1%) and EBITDA of ₹4.89 Lakh (EBITDA margin 3.9%).
Court records list 1 case involving the company, including 1 filed against it.
Greatlee Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0145898).
Company details
Recognitions & Rankings of Greatlee Pharmaceuticals
Contact details
Greatlee Pharmaceuticals Private Limited's registered office is in Sanand, Gujarat.
- Registered Address20 Jp Estate Opp. Chehar Mata Temple, Sanathal To Changodar Highway Navapura, Sanand, Gujarat, India – 382210
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Greatlee Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Greatlee Pharmaceuticals Private Limited, buy the company report.
Financials of Greatlee Pharmaceuticals Private Limited
FY 2025 filings availableGreatlee Pharmaceuticals Private Limited reported revenue of ₹1.24 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 7% in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹4.89 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.32 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.9% | |||
| Net Profit Margin | -1.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Greatlee Pharmaceuticals Private Limited, buy the company report.
Board of directors of Greatlee Pharmaceuticals Private Limited
Greatlee Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Riteshkumar Dineshkumar Thakkar Also directs: Duphar Lifesciences Private Limited, RHT Pharmaceuticals Private Limited, Roussel Laboratories Private Limited and 1 more | Director | 22 Feb 2022 | 4 Years 8 Months | Current |
| Krunal Dineshbhai Thakkar Also directs: Infar Wellness Private Limited, SKF Wellness Private Limited | Director | 22 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Greatlee Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bageo Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2022) | 45.0% | Salem, Tamil Nadu, India | |||
| Arushnova Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | 37.0% | Lucknow, Uttar Pradesh, India | |||
| Greatlee Pharmaceuticals Private Limitedthis company | ₹1.24 Cr (FY 2025) | -₹1.32 Lakh | -1.1% | 7.0% | Sanand, Gujarat, India | |
| Dermont Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | 14.0% | Jaipur, Rajasthan, India | |||
| Elixolife Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | -22.0% | Pilkhuwa, Uttar Pradesh, India |
To see the full peer comparison of Greatlee Pharmaceuticals Private Limited, buy the company report.
Legal cases
Greatlee Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by Unison Pharmaceuticals Pvt Ltd | Disposed |
To see the full case history of Greatlee Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Greatlee Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Greatlee Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCG5969Q1ZO | Gujarat | Active | 25 Apr 2022 |
To see the full GST registrations and return filing status of Greatlee Pharmaceuticals Private Limited, buy the company report.
Recent activity
Greatlee Pharmaceuticals Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Amitkumar Rasiklal Thakkar ceased to be Director on 17 Jan 2025.
Frequently asked questions
Greatlee Pharmaceuticals is an active private limited company based in Sanand, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 February 2022 (4+ years old) and is registered under CIN U24299GJ2022PTC129545.
Greatlee Pharmaceuticals has 2 current directors:
- Riteshkumar Dineshkumar Thakkar - Director
- Krunal Dineshbhai Thakkar - Director
The latest financial statements of Greatlee Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Greatlee Pharmaceuticals is 24AAJCG5969Q1ZO, registered in Gujarat.
The CIN (Corporate Identification Number) of Greatlee Pharmaceuticals is U24299GJ2022PTC129545. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Greatlee Pharmaceuticals has 1 court case on record: 1 filed against it.
Greatlee Pharmaceuticals was incorporated on 22 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Greatlee Pharmaceuticals by revenue are Bageo Pharmaceuticals Private Limited, Arushnova Pharmaceuticals Private Limited, Dermont Pharmaceuticals Private Limited, Elixolife Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Amitkumar Rasiklal Thakkar ceased to be Director on 17 Jan 2025. Vijaykumar Dhirajlal Thakkar ceased to be Director on 17 Jan 2025. Krunal Dineshbhai Thakkar was appointed as Director on 22 Feb 2022. Greatlee Pharmaceuticals has 4 board changes on record in total.
Yes, Greatlee Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0145898).
The registered office of Greatlee Pharmaceuticals is at 20 Jp Estate Opp. Chehar Mata Temple, Sanathal To Changodar Highway Navapura, Sanand, Gujarat, India – 382210.

